tiprankstipranks
Trending News
More News >
Love Pharma Inc (TSE:JOLT)
:JOLT
Canadian Market
Advertisement

Love Pharma Inc (JOLT) Technical Analysis

Compare
11 Followers

Summary of all the Indicators

Overall Consensus
Neutral
7Bullish
4Neutral
8Bearish
Technical Analysis Consensus
Sell
2Bullish
4Neutral
3Bearish
Moving Average Consensus
Neutral
5Bullish
0Neutral
5Bearish
Love Pharma Inc’s (JOLT) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting Love Pharma Inc is a Sell.
Love Pharma Inc’s (JOLT) 20-Day exponential moving average is 0.09, while Love Pharma Inc’s (JOLT) share price is <C$0.1, making it a Buy.
Love Pharma Inc’s (JOLT) 50-Day exponential moving average is 0.09, while Love Pharma Inc’s (JOLT) share price is <C$0.1, making it a Sell.

Love Pharma Inc (JOLT) Pivot Points

Aug 30, 2025, 02:10 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.08
0.08
0.09
0.09
0.09
0.09
0.10
Fibonacci
0.08
0.09
0.09
0.09
0.09
0.09
0.09
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Love Pharma Inc (JOLT) Moving Averages

Aug 30, 2025, 02:10 PM
Period
Simple
Exponential
MA5
0.09Sell
0.09Buy
MA10
0.09Buy
0.09Buy
MA20
0.08Buy
0.09Buy
MA50
0.09Sell
0.09Sell
MA100
0.10Sell
0.10Sell
MA200
Love Pharma Inc’s (JOLT) 10-Day exponential moving average is 0.09, while Love Pharma Inc’s (JOLT) share price is <C$0.1, making it a Buy.
Love Pharma Inc’s (JOLT) 100-Day exponential moving average is 0.10, while Love Pharma Inc’s (JOLT) share price is <C$0.1, making it a Sell.
Love Pharma Inc’s (JOLT) stock price is <C$0.1 and Love Pharma Inc’s (JOLT) 50-day simple moving average is 0.09, creating a Sell signal.
Love Pharma Inc’s (JOLT) stock price is <C$0.1 and Love Pharma Inc’s (JOLT) 100-day simple moving average is 0.10, creating a Sell signal.

Love Pharma Inc (JOLT) Technical Indicators

Aug 30, 2025, 02:10 PM
Name
Value
Implied Action
RSI (14)
59.35
Neutral
STOCH (9,6)
100.00
Sell
STOCHRSI (14)
100.00
Sell
MACD (12,26)
>-0.01
Sell
ADX (14)
30.26
Neutral
Williams %R
0.00
Buy
CCI (14)
88.58
Neutral
ATR (14)
<0.01
-
Ultimate Oscillator
68.69
Neutral
ROC
12.50
Buy
Love Pharma Inc’s (JOLT) Relative Strength Index (RSI) is 59.35, creating a Neutral signal.
Love Pharma Inc’s (JOLT) Trend Strength Indicator (ADX) is 30.26, creating a Neutral signal.
Love Pharma Inc’s (JOLT) Commodity Channel Index (CCI) is 88.58, creating a Neutral signal.
Love Pharma Inc’s (JOLT) Price Rate of Change (ROC) is 12.50, creating a Buy signal.

FAQ

Is JOLT a Buy, Hold, or Sell?
Based on JOLT’s technical indicators, JOLT is a Hold.
    What is JOLT’s RSI (14)?
    JOLT’s RSI (14) is 59.35, which suggests JOLT is a Neutral.
      What is JOLT’s MACD?
      JOLT’s MACD is >-0.01, which suggests JOLT is a Sell.
        What is JOLT’s 5-day moving average?
        JOLT’s 5-day moving average is 0.09, which suggests JOLT is a Sell.
          What is JOLT’s 20-day moving average?
          JOLT 20-day moving average is 0.08, which suggests JOLT is a Buy.
            What is JOLT’s 50-day moving average?
            JOLT’s 50-day moving average is 0.09, which suggests JOLT is a Sell.
              What is JOLT’s 200-day moving average?
              Currently, no data Available
              What is JOLT’s Williams % R (14)?
              JOLT’s Williams % R (14) is 0.00, which suggests JOLT is a Buy.
                What is JOLT’s CCI (14)?
                JOLT’s CCI (14) is 88.58, which suggests JOLT is a Neutral.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis